We are delighted to announce the appointment of Dr. Johannes Platzek as Chief Scientific Officer of APELOA CDMO BU.

Dr. Platzek, a distinguished organic chemist with over 30 years at Bayer, brings unparalleled expertise in drug development, process optimization, and project management. His leadership will significantly boost our technological innovation and research capabilities, ensuring we meet the personalized needs from our clients at every stage of drug development. We look forward to enhancing our services and becoming an even more trusted partner in the pharmaceutical industry.